Today, on January 19 2026, an extraordinary general meeting was held in Nexam Chemical Holding AB (publ). A summary of the adopted resolutions follows below.

Resolution on approval of the Board's resolution on rights issue of shares

The meeting resolved, in accordance with the Board's proposal, to approve the Board's resolution of 22 December 2025 on a rights issue of shares (the "Rights Issue"). Upon full subscription in the Rights Issue, the company will receive approximately SEK 51.8 million before issue costs.

The terms of the Rights Issue mean that each share in the company held on the record date of 22 January 2026 entitles the holder to one (1) subscription right, and fifteen (15) subscription rights entitle the holder to subscribe for four (4) new shares at a subscription price of SEK 2.40 per share. In total, the Rights Issue comprises a maximum of 21,577,544 shares. The subscription period for the Rights Issue runs from 26 January 2026 to 9 February 2026. Upon full subscription of all shares issued in the Rights Issue, the share capital will increase by a maximum of SEK 414,952.769242.

Resolution on authorisation for the Board to resolve on new issues of shares to guarantors

The meeting resolved, in accordance with the Board's proposal, in order to enable the issuance of shares as guarantee consideration to those who have entered into guarantee commitments (the "Guarantors") to secure the Rights Issue, to authorise the Board to, for the period until the next annual general meeting, on one or several occasions, with deviation from the shareholders' preferential rights and with or without conditions of set-off or other conditions, resolve on new issues of shares to the Guarantors.

Upon utilisation of the authorisation, the subscription price shall correspond to the volume-weighted average price (VWAP) for the company's share on Nasdaq First North Premier Growth Market during the subscription period in the Rights Issue, but never lower than the subscription price in the Rights Issue.

The purpose of the authorisation and the reason for the deviation from the shareholders' preferential rights is to be able to carry out a new issue of shares as compensation to the Guarantors. The number of shares that may be issued under the authorisation may not exceed the total number of shares corresponding to the agreed guarantee consideration that the company has to pay to the Guarantors.

Resolution on authorisation for the Board to resolve on new issues of additional shares in the event of oversubscription (over-allotment issue)

The meeting resolved, in accordance with the Board's proposal, to authorise the Board, for the period until the next annual general meeting, on one or more occasions, to resolve on the issue of 6,250,000 additional shares in the event of oversubscription in the Rights Issue. The right to subscribe for the new shares shall, with deviation from the shareholders' preferential rights, only be vested in the parties who have entered into top guarantee commitments in the Rights Issue (the "Top Guarantors"). New issues pursuant to the authorisation shall be made at a subscription price of SEK 2.40 per share, which corresponds to the subscription price in the Rights Issue.

The purpose of the authorisation and the reason for the deviation from the shareholders' preferential rights is to ensure that the Top Guarantors, in the event of oversubscription in the Rights Issue, receive allotment of shares corresponding to their submitted top guarantee commitments, and ensure the opportunity to provide the company with additional capital (so-called over-allotment issue). The Board considers that it is in the interests of both the company and its shareholders that the company, if applicable, can raise additional capital in a time- and cost-efficient manner through an over-allotment issue. The authorisation shall be available for utilisation by the Board, in whole or in part, to the extent that the Board deems appropriate.

In the event that the over-allotment issue is exercised in full, the share capital will increase by a maximum of SEK 120,192.307696.

Lomma on January 19 2026

Nexam Chemical Holding AB (publ)

For more information, please contact:

Ronnie Törnqvist, CEO, +46-706 25 41 85, ronnie.tornqvist@nexamchemical.com